• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-氮杂-2'-脱氧胞苷的体外细胞毒性和生化效应

In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine.

作者信息

Momparler R L, Goodman J

出版信息

Cancer Res. 1977 Jun;37(6):1636-9.

PMID:66984
Abstract

The in vitro effect of 5-aza-2'-deoxycytidine (5-aza-CdR) on cytotoxicity and macromolecular synthesis in A(T1)C1-3 hamster fibrosarcoma cells was investigated. The in vitro concentrations that produce 50% cell kill for 5-aza-CdR were about 1.0 and 0.01 microng/ml for a 2- and 24-hr exposure, respectively. 5-aza-CdR inhibited the growth of the fibrosarcoma cells by 40% at a concentration of 0.05 microng/ml. Deoxycytidine, but not cytidine, was a potent antagonist of the cytotoxicity produced by 5-aza-CdR. At cytotoxic concentrations 5-aza-CdR did not appear to inhibit DNA, RNA, or protein synthesis during a 1-hr incubation as measured by the incorporation of radioactive thymidine, uridine,, or leucine into acid-insoluble material. At a concentration of 10 microng/ml, 5-aza-CdR stimulated the incorporation of radioactive thymidine into DNA by more than 50%. These results indicate that 5-aza-CdR is a very potent cytotoxic agent to tumor cells in vitro at concentrations that do not inhibit macromolecular synthesis.

摘要

研究了5-氮杂-2'-脱氧胞苷(5-aza-CdR)对A(T1)C1-3仓鼠纤维肉瘤细胞的细胞毒性和大分子合成的体外作用。对于5-aza-CdR,2小时和24小时暴露产生50%细胞杀伤的体外浓度分别约为1.0和0.01微克/毫升。在浓度为0.05微克/毫升时,5-aza-CdR抑制纤维肉瘤细胞生长40%。脱氧胞苷而非胞苷是5-aza-CdR产生的细胞毒性的有效拮抗剂。在细胞毒性浓度下,通过将放射性胸苷、尿苷或亮氨酸掺入酸不溶性物质来测量,5-aza-CdR在1小时孵育期间似乎不抑制DNA、RNA或蛋白质合成。在浓度为10微克/毫升时,5-aza-CdR刺激放射性胸苷掺入DNA的量增加超过50%。这些结果表明,5-aza-CdR在不抑制大分子合成的浓度下是一种对肿瘤细胞非常有效的体外细胞毒性剂。

相似文献

1
In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine.5-氮杂-2'-脱氧胞苷的体外细胞毒性和生化效应
Cancer Res. 1977 Jun;37(6):1636-9.
2
Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.5-氮杂-2'-脱氧胞苷与3-脱氮尿苷对L1210白血病细胞和EMT6肿瘤细胞的协同作用。
Cancer Res. 1979 Oct;39(10):3822-7.
3
In vitro biochemical and cytotoxicity studies with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine in combination.1-β-D-阿拉伯呋喃糖基胞嘧啶与5-氮杂胞苷联合应用的体外生化及细胞毒性研究
Cancer Res. 1975 Oct;35(10):2853-7.
4
Depression of DNA synthesis in mouse spleen after treatment with 5-aza-2'-deoxycytidine.用5-氮杂-2'-脱氧胞苷处理后小鼠脾脏中DNA合成的抑制
J Natl Cancer Inst. 1979 Oct;63(4):1035-9.
5
Biological effects of inhibition of guanine nucleotide synthesis by mycophenolic acid in cultured neuroblastoma cells.霉酚酸抑制培养的神经母细胞瘤细胞中鸟嘌呤核苷酸合成的生物学效应。
Cancer Res. 1977 Sep;37(9):3314-20.
6
Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyrazofurin.5-氮杂胞苷在培养的诺维科夫大鼠肝癌细胞和P388小鼠白血病细胞中的代谢与细胞毒性及其与吡唑呋林预孵育后的增强作用
Cancer Res. 1978 Aug;38(8):2458-66.
7
Nucleosides and nucleotides. 180. Synthesis and antitumor activity of nucleosides that have a hydroxylamino group instead of a hydroxyl group at the 2'- or 3'-position of the sugar moiety.核苷与核苷酸。180. 糖部分2'-或3'-位具有羟氨基而非羟基的核苷的合成及其抗肿瘤活性。
J Med Chem. 1998 Dec 3;41(25):5094-107. doi: 10.1021/jm980466g.
8
Cellular phosphorylation of 1-beta-D-arabinofuranosylcytosine 5-azacytidine with intact fibrosarcoma and leukemic cells.1-β-D-阿拉伯呋喃糖基胞嘧啶5-氮杂胞苷在完整纤维肉瘤细胞和白血病细胞中的细胞磷酸化作用
Cancer Res. 1975 Sep;35(9):2506-10.
9
Antiproliferative effects and DNA hypomethylation by 5-aza-2'-deoxycytidine in human neuroblastoma cell lines.5-氮杂-2'-脱氧胞苷对人神经母细胞瘤细胞系的抗增殖作用及DNA低甲基化作用
Anticancer Drugs. 1993 Dec;4(6):629-35. doi: 10.1097/00001813-199312000-00004.
10
Relationship between the expression of estrogen-regulated genes and estrogen-stimulated proliferation of MCF-7 mammary tumor cells.雌激素调节基因的表达与雌激素刺激的MCF-7乳腺肿瘤细胞增殖之间的关系。
Cancer Res. 1985 Jun;45(6):2608-15.

引用本文的文献

1
Azacytidine treatment affects the methylation pattern of genomic and cell-free DNA in uveal melanoma cell lines.阿扎胞苷治疗影响葡萄膜黑素瘤细胞系中基因组和游离细胞 DNA 的甲基化模式。
BMC Cancer. 2024 Oct 21;24(1):1299. doi: 10.1186/s12885-024-13037-4.
2
Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes.CC-486(口服阿扎胞苷)延长给药方案在低危骨髓增生异常综合征患者中的疗效与安全性。
Leukemia. 2016 Apr;30(4):889-96. doi: 10.1038/leu.2015.265. Epub 2015 Oct 7.
3
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study.
瓜德西他滨(SGI-110)在骨髓增生异常综合征和急性髓系白血病患者中的安全性和耐受性:一项多中心、随机、剂量递增的1期研究。
Lancet Oncol. 2015 Sep;16(9):1099-1110. doi: 10.1016/S1470-2045(15)00038-8. Epub 2015 Aug 19.
4
Pharmacokinetics and Pharmacodynamics with Extended Dosing of CC-486 in Patients with Hematologic Malignancies.CC-486延长给药方案在血液系统恶性肿瘤患者中的药代动力学和药效学
PLoS One. 2015 Aug 21;10(8):e0135520. doi: 10.1371/journal.pone.0135520. eCollection 2015.
5
Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers.使用表观遗传修饰剂对人动员外周血干细胞进行体外扩增。
Transfusion. 2015 Apr;55(4):864-74. doi: 10.1111/trf.12904. Epub 2014 Nov 2.
6
Subchronic oral toxicity study of decitabine in combination with tetrahydrouridine in CD-1 mice.地西他滨联合四氢尿苷对CD-1小鼠的亚慢性经口毒性研究。
Int J Toxicol. 2014 Mar-Apr;33(2):75-85. doi: 10.1177/1091581814524994. Epub 2014 Mar 17.
7
Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy.5-氮杂-2'-脱氧胞苷(地西他滨)在癌症治疗方案设计中的药代动力学和药效学分析。
Clin Epigenetics. 2013 Feb 1;5(1):3. doi: 10.1186/1868-7083-5-3.
8
Increased CDA expression/activity in males contributes to decreased cytidine analog half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapy.男性中 CDA 表达/活性的增加导致胞苷类似物半衰期缩短,可能导致 5-氮杂胞苷或地西他滨治疗效果更差。
Clin Cancer Res. 2013 Feb 15;19(4):938-48. doi: 10.1158/1078-0432.CCR-12-1722. Epub 2013 Jan 3.
9
High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects.肝脏中高表达的胞苷脱氨酶为癌细胞提供了免受地西他滨治疗影响的庇护所。
Oncotarget. 2012 Oct;3(10):1137-45. doi: 10.18632/oncotarget.597.
10
p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.p53 非依赖性、正常干细胞保留的表观遗传分化治疗用于髓系和其他恶性肿瘤。
Semin Oncol. 2012 Feb;39(1):97-108. doi: 10.1053/j.seminoncol.2011.11.011.